Larvol Delta - Actimed-Therapeutics-announces-FDA-approval-of-its-Investigational-New-Drug-application-for-Phase-2b3-IMPACT-clinical-trials-of-Spindolol-benzoate-to-treat-cancer-cachexia

S-pindolol benzoate (ACM-001) - Actimed Therap

https://www.globenewswire.com/news-release/2023/09/07/2739001/0/en/Actimed-Therapeutics-announces-FDA-approval-of-its-Investigational-New-Drug-application-for-Phase-2b-3-IMPACT-clinical-trials-of-S-pindolol-benzoate-to-treat-cancer-cachexia.html

Sep 7, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next